Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 50 of 1356 results for patients and public

  1. Highly specialised technologies evaluation committee

    Members are appointed for a 3-year term, and are drawn from: the NHS patient and carer organisations academia pharmaceuticals and...

  2. Lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema (IPG785)

    Evidence-based recommendations on lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema in adults. This involves diverting some of the lymphatic vessels around where lymph nodes have been removed to nearby veins.

  3. Our projects and partners

    NICE research projects and partners.

  4. Technology appraisal committee

    Details, meeting dates and minutes of the independent technology appraisal committees

  5. Executive team

    Biographies of the NICE executive team and minutes of their meetings

  6. Committee D members

    Find out more about NICE technology appraisals advisory committee D members

  7. Overview: how we develop technology appraisal guidance

    commentators. Consultee organisations include: national groups representing patients and carers bodies representing healthcare...

  8. GaitSmart rehabilitation exercise programme for gait and mobility issues (MTG78)

    Evidence-based recommendations on GaitSmart rehabilitation exercise programme for gait and mobility issues in adults.

  9. Medical technologies advisory committee members

    working closely across all tiers of the trust to improve the delivery of safe patient care. He is also the Acute Care Common Stem...

  10. Our charter

    An outline of the roles and responsibilities of the National Institute for Health and Care Excellence

  11. Ovarian cancer: identifying and managing familial and genetic risk (NG241)

    This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults.

  12. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (NG240)

    This guideline covers recognising, diagnosing and managing bacterial meningitis and meningococcal disease in babies, children, young people and adults. It aims to reduce death and disability by helping healthcare professionals recognise meningitis and treat it quickly and effectively.

  13. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

  14. Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)

    Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.

  15. Guides to developing our guidance

    Resources to help organisations who want to help develop NICE guidance

  16. NICE and health inequalities

    Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged

  17. Women inspiring inclusion in NICE guidance

    This International Women’s Day, we’re specifically focusing on the invaluable contributions of two of the women who help shape our guidance through their independent / voluntary committee roles. Hear from them, as they talk about their involvement with NICE and what #InspireInclusion means to them.

  18. Lung cancer: diagnosis and management (NG122)

    This guideline covers diagnosing and managing non-small-cell and small-cell lung cancer. It aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to suitable palliative care and follow-up.

  19. Board

    Our board sets out our strategic priorities and policies.

  20. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239)

    This guideline covers recognising, diagnosing and managing vitamin B12 deficiency in people aged 16 and over, including deficiency caused by autoimmune gastritis. It also covers monitoring for gastric cancer in people with autoimmune gastritis.

  21. Up to 14,000 people could benefit from the first treatment for severe alopecia recommended by NICE

    New one-a-day tablet for people with severe hair loss due to alopecia areata recommended by NICE

  22. Committee B members

    Find out more about the NICE technology appraisal advisory committee B members and their registered interests

  23. Highly specialised technologies evaluation committee members

    Highly specialised technologies evaluation committee members

  24. NICE voluntary and community sector forum

    use health and social care services, their families and carers, and the public local Healthwatch organisations and local organisations...

  25. Tuberculosis (NG33)

    This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services should be organised, including the role of the TB control board.

  26. Our programmes

    The different types of health, public health and social care information provided by NICE.

  27. Appeal panel membership

    the NHS or public health service in the UK someone with experience in representing patients or carers, or who is a...

  28. Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over (TA949)

    Evidence-based recommendations on belumosudil (Rezurock) for chronic graft-versus-host disease in people 12 years and over after 2 or more systemic treatments.

  29. Indicator advisory committee (IAC)

    and secondary care professionals commissioners public health and social care professionals patients or service users and...

  30. Committee A members

    Biographies and registered interests for members of the Technology Appraisal Committee A

  31. NICE Advice service

    NICE advice is a support service for pharmaceutical and healthtech companies seeking to enter the NHS market.

  32. Caesarean birth (NG192)

    This guideline covers when to offer and discuss caesarean birth, procedural aspects of the operation, and care after caesarean birth. It aims to improve the consistency and quality of care for women and pregnant people who are thinking about having a caesarean birth or have had a caesarean birth in the past and are now pregnant again.

  33. CKS end user licence agreement

    CKS end user licence agreement

  34. Diagnostics advisory committee members

    Diane Davies Biography Lay member. Diane worked in education, public health and community regeneration roles before leaving to care for...

  35. Skin cancer (QS130)

    This quality standard covers preventing, assessing, diagnosing and managing skin cancer (melanoma and non-melanoma skin cancer). It describes high-quality care in priority areas for improvement.

  36. Pharyngeal electrical stimulation for neurogenic dysphagia (IPG781)

    Evidence-based recommendations on pharyngeal electrical stimulation for neurogenic dysphagia. This involves passing a catheter through the nose and into the throat where it is used to deliver small amounts of electrical current. The current travels from the throat to the brain and stimulates the areas involved in swallowing.

  37. Developing NICE guidelines: the manual (PMG20)

    Developing NICE guidelines: the manual

  38. General practice

    appraisals, clinical guidelines and selected interventional. procedures and public health guidance. Tailor for general practice by...

  39. Structure of NICE

    NHS, local government, social care, patients and their families. Responsible for: clinical guidelines public health...

  40. OpenAthens eligibility

    NHS-commissioned care in England. The individual must be working directly with NHS patients (B) Examples: independent, private,...

  41. Health Technology Assessment Innovation Laboratory (HTA Lab)

    NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

  42. Intravascular lithotripsy for calcified arteries in peripheral arterial disease (IPG780)

    Evidence-based recommendations on intravascular lithotripsy for calcified arteries in peripheral arterial disease. This involves using pressure waves to soften arterial plaque and widen the artery to improve blood flow.

  43. NICE interventional procedures guidance

    things like: making a cut or a hole to gain access to the inside of a patient's body, for example an operation or inserting a tube into...

  44. NICE talks podcasts

    podcasts bring you the real life experiences of people working within the NHS, public health and social care. Hear the stories behind...

  45. Interventional procedures advisory committee members

    Interventional Procedures Advisory Committee members

  46. Listening to patients and organisations to update NICE's quality standard on transition from children's to adults' services

    Melanie explains how the update to NICE’s quality standard on the transition from children’s to adults’ services will benefit young people, their families and carers

  47. Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)

    This guideline covers identifying and assessing risk of cardiovascular disease (CVD) in adults without established CVD. It covers lifestyle changes and lipid-lowering treatment (including statins) for primary and secondary prevention of CVD, and includes guidance for people who also have diabetes or chronic kidney disease.

  48. Supporting the health and care system to implement virtual wards

    team at North Tees and Hartlepool NHS Foundation Trust as they support patients in their homes. Our latest virtual wards guidance and...

  49. Public board meeting agenda and papers: September 2023

    Agenda and papers of the NICE public board meeting on 21 September 2023

  50. Acne vulgaris: management (NG198)

    This guideline covers management of acne vulgaris in primary and specialist care. It includes advice on topical and oral treatments (including antibiotics and retinoids), treatment using physical modalities, and the impact of acne vulgaris on mental health and wellbeing.